NEW YORK (GenomeWeb News) – Insight Genetics and Kindstar Globalgene Technology announced Thursday evening a licensing deal for the Insight ALK Screen lung cancer test.

Under the terms, Insight ALK Screen will be added to Kindstar's menu of tests directed at cancer diagnosis and care offered in China and surrounding areas. Kindstar anticipates offering Insight ALK Screen in China, Hong Kong, and Macau starting next month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.